13F Insight
DOSSIER · 13F Holders · Q1 2026

THERAVANCE BIOPHARMA INC

184 institutions still hold THERAVANCE BIOPHARMA INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP G8807B106·184 13F holders·last filed Mar 31, 2026
Market cap
—
13F value held
$687M
visible holders
Holders
184
filers reporting
Concentration
22.47%
Madison Avenue Partners, LP #1
top holder share
AI Holders Summary · Q1 2026

184 institutions reported THERAVANCE BIOPHARMA INC in Q1 2026. Madison Avenue Partners, LP leads at 22.5% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Madison Avenue Partners, LP
CIK 0001801265
$154M9.5M6.71%Q1 202602
Weiss Asset Management LP
CIK 0001357550
$121M7.5M2.05%Q1 202603
Newtyn Management, LLC
CIK 0001569241
$79M4.8M8.40%Q1 202604
BlackRock, Inc.
CIK 0002012383
$70M4.3M0.00%Q1 202605
Irenic Capital Management LP
CIK 0001929389
$45M2.8M2.92%Q1 202606
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$29M1.8M0.00%Q1 202607
D. E. Shaw & Co., Inc.
CIK 0001009207
$24M1.3M0.01%Q4 202508
STATE STREET CORP
CIK 0000093751
$21M1.3M0.00%Q1 202609
ACADIAN ASSET MANAGEMENT LLC
CIK 0000916542
$21M1.3M0.03%Q1 202610
TWO SIGMA INVESTMENTS, LP
CIK 0001179392
$20M1.3M0.02%Q1 202611
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$18M1.1M0.00%Q1 202612
DIMENSIONAL FUND ADVISORS LP
CIK 0000354204· Quasi-passive
$16M984K0.00%Q1 202613
UBS Group AG
CIK 0001610520
$12M764K0.00%Q1 202614
SUSQUEHANNA INTERNATIONAL GROUP, LLP
CIK 0001446194· Market maker
$11M668K0.00%Q1 202615
Oasis Management Co Ltd.
CIK 0001317904
$9M583K0.55%Q1 202616
MORGAN STANLEY
CIK 0000895421
$8M510K0.00%Q1 202617
MARSHALL WACE, LLP
CIK 0001318757
$8M419K0.01%Q4 202518
TWO SIGMA ADVISERS, LP
CIK 0001478735
$7M380K0.01%Q4 202519
GOLDMAN SACHS GROUP INC
CIK 0000886982
$7M416K0.00%Q1 202620
Caption Management, LLC
CIK 0001706766
$7M412K0.04%Q1 2026
Page 1 of 10
164 more holders available. Log in →